|
|
|
Speakers
| Payers |
|
Industry |
 |
Professor Finn Børlum
Kristensen
EUnetHTA
|
 |
Omar Ali
Formulary Development Pharmacist for Surrey & Sussex NHS Trust, ERG Cost Impact Modeling for NICE |
 |
Dr Steffen Thirstrup
Danish Medicines Agency
|
 |
Flemming Sonne
Amgros
|
 |
Marc Bardou
HAS
|
 |
Detlev Parow
DAK-Gesundheit |
 |
Susan KNOX
Executive Director - European
Breast Cancer Coalition |
 |
Dr Denis Lacombe
Director EORTC |
| |
Herve Drevot
CWHCP
|
| |
Oriol Sala Morales
HTA drug board
|
| |
Mathias Flume
Kassenarztliche
|
|
 |
Amy Rudolph
Novartis
|
 |
Tehseen Salimi
Sanofi Aventis
|
 |
Olivier Ethgen
GSK
|

 |
Rick Lones
BMS
ABPI
|
 |
Olivier Ethgan
GSK
|
 |
Ulf Staginnus
Amgen
|
 |
Philippe Fonjallaz
Merch Serono
|
 |
Alex Stojanovic
Grünenthal GmbH |
|
Back to Top
|
|
|
|
|
|
|
Join us on LinkedIn |
Testimonials
Having played a part in the ideas stage I am so glad to see that the summit has developed a programme that will meet my requirments to strenghthen the commercial objectives. Not only for future delevopment programmes, but also help my business unit to shape our existing pipeline to suit.
Clinical Development Director, Roche
Meeting with payers is something we have been trying to do for the past few years. Its great to know that this event will help me to do so.
Market Access Lead, Pfizer
The combination of pharma and payer insight is something very new and very exciting, it is a must attend event for me and my team.
Head Clinical Operations, GSK
|
|